Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial. Skipper C, Atukunda M, Stadelman A, Engen N, et al. Antimicrob Agents Chemother 2020 Aug 3. pii: AAC.00838.

Read + Share

Amedeo Smart

Independent Medical Education

Skipper C, Atukunda M, Stadelman A, Engen N, et al. Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial. Antimicrob Agents Chemother 2020 Aug 3. pii: AAC.00838.
PMID: 32747357